Scientists at Pittsburgh Medical University believe they have found a potential vaccine for the coronavirus.
A new bearer of hope. The very serious medical journal “LancetReveals a study by several scientists at the Pittsburgh University of Medicine in the United States, which reports a possible vaccine against the coronavirus. With much of the world confined, researchers around the world are more than ever working to find a way to counter the pandemic. The Pittsburgh team announced the results of their discoveries on Thursday. She believes she has developed a rapid vaccine “that could have a significant impact against the spread of the virus.”
This new vaccine would be delivered in the form of a small patch to be placed on the finger. “It looks very much like a bandage made up of very small needles in which we incorporate the vaccine directly”, explains doctor Louis Falo, quoted by CBS Pittsburgh. Each of the 400 micro-needles is the width of a human hair and only half a millimeter long. Everything is made up of liquid sugar to which the vaccine is added. “When the micro-needles are hard, they can penetrate the layers of the skin. And while they absorb its moisture, they dissolve and release the antigen into the skin, “reports Louis Falo.
Researchers from @PittHealthSci tested a potential vaccine against SARS-CoV-2, which produced SARS-CoV-2 antibodies in mice at quantities thought to be sufficient for neutralizing the virus. The vaccine is delivered through a fingertip-sized patch. https://t.co/rxYKTQ8NhOpic.twitter.com/AZzrCKN9jQ
– UPMC (@UPMCnews) April 2, 2020
“Our only competition here is against the virus”
Scientists said they quickly found this possible vaccine thanks to similar research on Sras and Mers, two other known coronaviruses. “These two viruses, which are close to SARS-CoV-2, have taught us that a particular protein, called peak protein, is important for inducing immunity against the virus,” said Dr. Andrea Gambotto, co-author of the study. “We knew exactly where to look to fight this new virus,” she continues. The Lancet says the vaccine has been tested in mice and appears to have produced enough antibodies in two weeks to counter the virus. As with the flu vaccine, scientists used pieces of viral protein made in the lab here, which were then used to boost immunity.
But these encouraging results do not mean that the vaccine can be put in place quickly. As with every study, human clinical trials must now be set up, which normally can take several years. The study authors have already made the request to the American authorities and hope to be able to speed things up. “Our only competition here is against the virus. I think we all want to go in the same direction. And I think that everything is better when we do not oppose each other and we collaborate together, because the virus is the real enemy here, “comments Louis Falo.
Any reproduction prohibited